Archive for February 2019
Milica Vukmirovic, PhD
Milica Vukmirovic, PhD, holds the position of Blavatnik Fellow in Life Science Entrepreneurship at the Office of Cooperative Research (OCR) and Blavatnik Innovation Fund at Yale University. She works on commercialization of medical breakthrough innovations across Yale and assists Blavatnik Innovation Fund activities. She recently was elected as the Chair of the newly formed ATS…
Read MoreLonny Yarmus, DO, MBA FCCP, ATSF
Lonny Yarmus, DO, MBA FCCP, ATSF, is an Associate Professor of Medicine and Oncology and Clinical Chief of the Division of Pulmonary and Critical Care Medicine at Johns Hopkins University School of Medicine. He also serves as the Director of the Center for Interventional Pulmonary Research at Johns Hopkins University. Dr. Yarmus is an interventional…
Read MoreJason Pesterfield
Jason has been in the Med-Tech space for 25 years with the majority of his career spent leading efforts around the development and commercialization of cutting edge technologies such as surgical power tools, navigation and robotics. At Veran, Jason and his team’s mission is to enable thoracic and interventional specialists to diagnose soft tissue cancers…
Read MoreC. Matthew Kinsey, MD, MPH
Dr. Kinsey directs the Interventional Pulmonary Program at the University of Vermont Medical Center. This program focuses on advanced diagnostic and therapeutic procedures to address thoracic diseases, and includes endobronchial valve placement for advanced emphysema, intraoperative cone beam navigational bronchoscopy, holmium and Nd:YAG laser therapy, airway stenting, and direct tumoral therapies (Endobronchial Ultrasound-Guided Transbronchial Needle…
Read MoreWade Lange
With diverse experience in the life sciences industry, Wade Lange’s background encompasses broad experience in the areas of biotechnology entrepreneurship, clinical research, marketing, marketing research, business development and general management in the pharmaceutical, medical device and healthcare sectors. As president & CEO of ImmuneWorks he led the company from formation through completion of its Phase…
Read MoreJonathan Waldstreicher, MD, MBA
Jonathan Waldstreicher, Principal, joined Apple Tree Partners in 2013 to invest in medical devices. After incubating an interventional pulmonary technology for two years, Jon founded Gala Therapeutics in Silicon Valley and assumed the CEO role to further its development. Prior to joining ATP, Jon was a Director, Global Surgery R&D, at Johnson & Johnson where…
Read More